Kelly is a proven leader with over 25 years of experience in the charitable, health and public sectors. Kelly joined Cystic Fibrosis Canada as the President and Chief Executive Officer in June 2018. In her tenure with the organization, she led the development of a new strategic plan, navigated through challenges due to the pandemic and most recently was part of a wonderful success story with the approval of a transformational drug for people diagnosed with cystic fibrosis. Kelly was previously with Ovarian Cancer Canada as the Vice-President, National Programs and Partners. Kelly holds both master’s and bachelor’s degrees from Queen’s University.
Board of Directors and Senior Team
Kelly Grover